SCHEMBL7529612

SCHEMBL7529612

[O]c1ccc(SOC(F)(F)F)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10983672 0.77 ALDH1A1 (0.52)
SCHEMBL10983784 0.74 KDM4E (0.34)
SCHEMBL5919663 0.71
SCHEMBL2303866 0.69
SCHEMBL12148684 0.66 KMT2A (0.33)
SCHEMBL9985864 0.64
SCHEMBL9480539 0.63 NR1H2 (0.47)
SCHEMBL5546729 0.59 SLC6A4 (0.45)
SCHEMBL186746 0.59 CES2 (0.52)
SCHEMBL714545 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1192178-A2 RUFOMYCINS AND DERIVATIVES THEREOF USEFUL AS INHIBITORS OF MULTI-DRUG RESISTANCE ASSOCIATED PROTEIN-1 (MRP-1) ELI LILLY AND COMPANY (US) 2002-04-03 EP claimed
WO-2000078795-A2 RUFOMYCINS AND DERIVATIVES THEREOF USEFUL AS INHIBITORS OF MULTI-DRUG RESISTANCE ASSOCIATED PROTEIN-1 (MRP-1) ELI LILLY AND COMPANY (US) 2000-12-28 WO claimed